108 related articles for article (PubMed ID: 2274425)
1. [Statistical correlations of the duration of survival and prognostic factors in the group of patients with Hodgkin's disease].
Mierzwińska J; Gałecki J; Mykowiecka A
Nowotwory; 1990; 40(2):138-42. PubMed ID: 2274425
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
Kim HK; Silver B; Li S; Neuberg D; Mauch P
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.
Coiffier B
Curr Opin Oncol; 1991 Oct; 3(5):843-51. PubMed ID: 1751578
[TBL] [Abstract][Full Text] [Related]
7. The prognosis of Hodgkin's disease in older adults.
Guinee VF; Giacco GG; Durand M; van den Blink JW; Gustavsson A; McVie JG; Zewuster R; Dische S; Fahey T; Lane W
J Clin Oncol; 1991 Jun; 9(6):947-53. PubMed ID: 2033430
[TBL] [Abstract][Full Text] [Related]
8. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
10. An analysis of prognostic factors in early stage Hodgkin's disease.
Horwich A; Easton D; Nogueira-Costa R; Liew KH; Colman M; Peckham MJ
Radiother Oncol; 1986 Oct; 7(2):95-106. PubMed ID: 3786824
[TBL] [Abstract][Full Text] [Related]
11. Long survival in Hodgkin's disease.
Chawla PL; Stutzman L; Dubois RE; Kim U; Sokal JE
Am J Med; 1970 Jan; 48(1):85-92. PubMed ID: 5415408
[No Abstract] [Full Text] [Related]
12. Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.
Dyduch M; Skolyszewski J; Korzeniowski S; Sokolowski A
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):634-43. PubMed ID: 12788168
[TBL] [Abstract][Full Text] [Related]
13. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
[No Abstract] [Full Text] [Related]
14. The prognostic value of HLA phenotypes in Hodgkin's disease.
Osoba D; Falk JA; Sousan P; Ciampi A; Till JE
Cancer; 1980 Oct; 46(8):1825-32. PubMed ID: 7427885
[TBL] [Abstract][Full Text] [Related]
15. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
16. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
17. [Hodgkin's disease: the effect of age on prognosis].
Burgers JM; el Sharouni SY; van Leeuwen FE; Somers R; Hart AA
Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1354-7. PubMed ID: 3412504
[No Abstract] [Full Text] [Related]
18. Hodgkin's disease in northern Sweden 1971-1981. II. A retrospective analysis of prognostic factors.
Norberg B; Dige U; Roos G; Johansson H; Lenner P
Acta Oncol; 1991; 30(5):597-601. PubMed ID: 1892677
[TBL] [Abstract][Full Text] [Related]
19. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of survival in Hodgkin's disease.
Aisenberg AC; Goldman JM
Cancer; 1971 Apr; 27(4):802-5. PubMed ID: 5574070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
